Humidity-Sensitive Drug Stabilization via Drying Agent
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
DFP-11207, a promising anti-cancer drug candidate, is unstable due to its sensitivity to humidity, which complicates long-term storage and transportation.
Innovation Solution
Formulating DFP-11207 with a hygroscopic agent and providing it in a container with a drying agent, such as silica gel, to suppress water molecule movement and enhance stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DFP-11207 is formulated as an oral preparation, then medicinal effects are improved with balanced pharmacokinetics, but storage stability deteriorates due to humidity sensitivity
Solution Approach 1:
The patent introduces a drying agent as an intermediary substance that mediates between the humid environment and the humidity-sensitive DFP-11207 compound. The drying agent absorbs excess moisture in the container headspace, creating a protected microenvironment that prevents hydrolysis of the ester bonds in DFP-11207 while allowing the compound to maintain its oral formulation and pharmacokinetic benefits
Solution Approach 2:
The patent creates an inert storage environment by controlling the humidity within the container through the drying agent. This establishes a low-humidity atmosphere that is chemically inert toward the ester bonds of DFP-11207, preventing degradation while maintaining the compound's stability and efficacy for long-term storage
2Ease of operation
If DFP-11207 is stored at room temperature for long term, then ease of operation is improved, but stability deteriorates due to humidity
Solution Approach 1:
The patent implements a self-service stabilization system where the drying agent automatically absorbs moisture from the container environment without requiring external intervention. This passive moisture control mechanism allows the preparation to self-regulate its storage conditions at room temperature, maintaining stability without requiring refrigeration or active humidity control systems
Solution Approach 2:
The patent changes the humidity parameter within the container by introducing a drying agent that actively modifies the local moisture environment. This parameter change creates a stable, low-humidity microclimate that protects DFP-11207 from degradation while allowing the preparation to be stored at convenient room temperature conditions
3Stability of the object's composition
If DFP-11207 is provided in container with drying agent, then stability is improved, but device complexity increases
Solution Approach 1:
The patent segments the storage system into two functional components: the DFP-11207 preparation and the drying agent. This segmentation allows each component to perform its specific function independently - the preparation provides medicinal benefits while the drying agent provides stability protection - simplifying the overall design compared to complex controlled-environment storage systems
Solution Approach 2:
The patent employs a simple, inexpensive drying agent that can be easily incorporated into the container system. The drying agent acts as a disposable stability-enhancing component that does not require complex mechanisms, sophisticated materials, or elaborate assembly procedures, thereby minimizing the increase in device complexity while effectively improving stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly stabilizes DFP-11207, allowing it to be stored for extended periods at room temperature or in a refrigerator with maintained purity and effectiveness, overcoming storage and transportation challenges.
Implementation Method 1
providing it in a container with a drying agent, such as silica gel, to suppress water molecule movement
Implementation Method 2
Formulating DFP-11207 with a hygroscopic agent and providing it in a container with a drying agent
Data Source
AI summary
An object of the present invention is to provide a method for stabilizing a substance DFP-11207 sensitive to humidity and unstable at high humidity, and a stabilized preparation thereof, and more specifically, provide a capsule preparation for treating cancer, containing DFP-11207 or a pharmaceutically acceptable salt thereof and a hygroscopic agent.


